Literature DB >> 25720346

Surgery in extensive vertebral hemangioma: case report, literature review and a new algorithm proposal.

Roberto Tarantino1, Pasquale Donnarumma, Lorenzo Nigro, Roberto Delfini.   

Abstract

Hemangiomas are benign dysplasias or vascular tumors consisting of vascular spaces lined with endothelium. Nowadays, radiotherapy for vertebral hemangiomas (VHs) is widely accepted as primary treatment for painful lesions. Nevertheless, the role of surgery is still unclear. The purpose of this study is to propose a novel algorithm of treatment about VHs. This is a case report of an extensive VH and a review of the literature. A case of vertebral fracture during radiotherapy at a total dose of 30 Gy given in 10 fractions (treatment time 2 weeks) using a linear accelerator at 15 MV high-energy photons for extensive VH is reported. Using PubMed database, a review of the literature is done. The authors have no study funding sources. The authors have no conflicting financial interests. In the literature, good results in terms of pain and neurological deficits are reported. No cases of vertebral fractures are described. However, there is no consensus regarding the treatment for VHs. Radiotherapy is widely utilized in VHs determining pain. Surgery for VHs determining neurological deficit is also widely accepted. Perhaps, regarding the width of the lesion, no indications are given. We consider it important to make an evaluation before initiating the treatment for the risk of pathologic vertebral fracture, since in radiotherapy, there is no convention regarding structural changes determined in VHs. We propose a new algorithm of treatment. We recommend radiotherapy only for small lesions in which vertebral stability is not concerned. Kyphoplasty can be proposed for asymptomatic patients in which VHs are small and in patients affected by VHs determining pain without spinal canal invasion in which the VH is small. In patients affected by pain without spinal canal invasion but in which the VH is wide or presented with spinal canal invasion and in patients affected by neurological deficits, we propose surgery.

Entities:  

Mesh:

Year:  2015        PMID: 25720346     DOI: 10.1007/s10143-015-0616-4

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  22 in total

1.  Surgical treatment of symptomatic vertebral haemangiomas.

Authors:  Roman Jankowski; Stanisław Nowak; Ryszard Zukiel; Janusz Szymaś; Bartosz Sokół
Journal:  Neurol Neurochir Pol       Date:  2011 Nov-Dec       Impact factor: 1.621

Review 2.  Primary bone tumors of the spine. Terminology and surgical staging.

Authors:  S Boriani; J N Weinstein; R Biagini
Journal:  Spine (Phila Pa 1976)       Date:  1997-05-01       Impact factor: 3.468

3.  Radiotherapy of vertebral hemangiomas.

Authors:  K Sakata; M Hareyama; A Oouchi; M Sido; H Nagakura; M Tamakawa; H Akiba; K Morita
Journal:  Acta Oncol       Date:  1997       Impact factor: 4.089

Review 4.  Treatment of Enneking stage 3 aggressive vertebral hemangiomas with intralesional spondylectomy: report of 10 cases and review of the literature.

Authors:  Frank L Acosta; Nader Sanai; Jordan Cloyd; Vedat Deviren; Dean Chou; Christopher P Ames
Journal:  J Spinal Disord Tech       Date:  2011-06

5.  Vertebral hemangioma: an important differential in the evaluation of locally aggressive spinal lesions.

Authors:  Justin Alexander; Adam Meir; Nikitas Vrodos; Yun-Hom Yau
Journal:  Spine (Phila Pa 1976)       Date:  2010-08-15       Impact factor: 3.468

6.  Symptomatic vertebral haemangiomas.

Authors:  V L McAllister; B E Kendall; J W Bull
Journal:  Brain       Date:  1975-03       Impact factor: 13.501

7.  Radiotherapy in the treatment of vertebral hemangiomas.

Authors:  S L Faria; W R Schlupp; H Chiminazzo
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-02       Impact factor: 7.038

Review 8.  Radiotherapy for symptomatic vertebral hemangiomas: results of a multicenter study and literature review.

Authors:  Reinhard Heyd; M Heinrich Seegenschmiedt; Dirk Rades; Cornelia Winkler; Hans T Eich; Frank Bruns; Georg Gosheger; Normann Willich; Oliver Micke
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-08-21       Impact factor: 7.038

9.  The natural history and management of symptomatic and asymptomatic vertebral hemangiomas.

Authors:  M W Fox; B M Onofrio
Journal:  J Neurosurg       Date:  1993-01       Impact factor: 5.115

10.  Is there a dose-effect relationship for the treatment of symptomatic vertebral hemangioma?

Authors:  Dirk Rades; Amira Bajrovic; Winfried Alberti; Volker Rudat
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-01-01       Impact factor: 7.038

View more
  6 in total

Review 1.  [Skeletal hemangiomas].

Authors:  M Rickert; A Meurer
Journal:  Orthopade       Date:  2017-05       Impact factor: 1.087

2.  Vertebral hemangiomas: common lesions with still many unknown aspects.

Authors:  Lorenzo Nigro; Pasquale Donnarumma
Journal:  J Spine Surg       Date:  2017-06

3.  A Symptomatic Case of Thoracic Vertebral Hemangioma Causing Lower Limb Spastic Paresis.

Authors:  Mohammad Alfawareh; Tariq Alotaibi; Abdallah Labeeb; Ziad Audat
Journal:  Am J Case Rep       Date:  2016-10-31

Review 4.  Surgical management of symptomatic vertebral hemangiomas: A case report and literature review.

Authors:  Harman Chopra; Haydn Hoffman; Timothy E Richardson; Michael A Galgano
Journal:  Surg Neurol Int       Date:  2021-02-17

5.  The Role of Radiotherapy and Surgery in the Management of Aggressive Vertebral Hemangioma: A Retrospective Study of 20 Patients.

Authors:  Ben Wang; Na Meng; Hongqing Zhuang; Songbo Han; Shaomin Yang; Liang Jiang; Feng Wei; Xiaoguang Liu; Zhongjun Liu
Journal:  Med Sci Monit       Date:  2018-09-27

6.  Intraoperative injection of absorbable gelatin sponge (AGS) mixed with cement followed by spinal decompression to treat elderly with vertebral hemangiomas.

Authors:  Weihong Xu; Zhibin Lan; Yuming Huang
Journal:  BMC Musculoskelet Disord       Date:  2020-02-24       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.